Fig. 6From: Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical productionIllustrated examples of in vivo engineered lanthipeptides. The structures of nisin (showing the nisin-lipid II binding motif and the hinge region which are highly implicated in the activity of the compound), Mutacin 1140 and Nukacin-ISK1Back to article page